Image 2_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.tiff gan Elisabeth Damisch (22679276)

Pynciau:

Image 4_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.tiff gan Elisabeth Damisch (22679276)

Pynciau:

Image 6_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.tiff gan Elisabeth Damisch (22679276)

Pynciau:

Table 1_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.xlsx gan Elisabeth Damisch (22679276)

Pynciau:

Image 1_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.tiff gan Elisabeth Damisch (22679276)

Pynciau:

Image 8_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.tiff gan Elisabeth Damisch (22679276)

Pynciau:

Image 7_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.tif gan Elisabeth Damisch (22679276)

Pynciau:

Image 5_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.tiff gan Elisabeth Damisch (22679276)

Pynciau:

Image 3_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.tiff gan Elisabeth Damisch (22679276)

Pynciau:

Data Sheet 1_Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.docx gan Elisabeth Damisch (22679276)

Pynciau:

Processed single-cell RNA-seq dataset of cancer-associated fibroblasts in breast cancer patients receiving anti–PD-1 therapy gan Thang Pham (19938126)

Pynciau: